ContractClinical Study Agreement • January 8th, 2019
Contract Type FiledJanuary 8th, 2019Clinical Study Agreement Protocol: AR-105-002 Site: XXXXX XXXXX ARIDIS PHARMACEUTICALS, INC. 03-August-2017 Version: Version #1 Country: czech republic CLINICAL STUDY AGREEMENT This clinical study agreement (“Agreement”), dated 03-August-2017 is entered into by and among Medpace Clinical Research, LLC, with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227 ("Medpace”); and Krajska zdravotni, a.s, with its principal office and place of business at Socialni pece 3316/12a, 401 13 Usti nad Labem, Czech Republic ("Institution”). Medpace and Institution are sometimes collectively referred to herein as parties (the “Parties”). WHEREAS, Aridis Pharmaceuticals, Inc. (“Sponsor”) is sponsoring a clinical study on Aerucin® (aerumab, AR-105) (the “Study Drug”), in accordance with Protocol No. AR-105-002, titled “Placebo-controlled, double-blind, randomized study of Aerucin® as adjunct therapy